Still the most comprehensive reference source on the development, production and therapeutic application of antibodies, this second edition is thoroughly updated and now has 30% more content.
Volume 1 covers selection and engineering strategies for new antibodies, while the second volume presents novel therapeutic concepts and antibodies in clinical study, as well as their potential. Volumes 3 and 4 feature detailed and specific information about each antibody approved for therapeutic purposes, including clinical data. This unique handbook concludes with a compendium of marketed monoclonal antibodies and an extensive index.
Beyond providing current knowledge, the authors discuss emerging technologies, future developments, and intellectual property issues, such that this handbook meets the needs of academic researchers, decision makers in industry and healthcare professionals in the clinic.
Volume 1 covers selection and engineering strategies for new antibodies, while the second volume presents novel therapeutic concepts and antibodies in clinical study, as well as their potential. Volumes 3 and 4 feature detailed and specific information about each antibody approved for therapeutic purposes, including clinical data. This unique handbook concludes with a compendium of marketed monoclonal antibodies and an extensive index.
Beyond providing current knowledge, the authors discuss emerging technologies, future developments, and intellectual property issues, such that this handbook meets the needs of academic researchers, decision makers in industry and healthcare professionals in the clinic.
Betala smidigt med kort, Klarna, Apple Pay eller Google Pay. Är du inte nöjd har du alltid 14 dagars ångerrätt. Läs mer i våra villkor. Har du några frågor, mejla oss på hello@memmo.org.
Memmo gör det enklare att plugga – var du än är i världen. Hos oss samlar du kursböcker och smarta studieverktyg på ett och samma ställe: sammanfattningar, quiz, poddar och flashcards. Och så Ted, din studiekompis som svarar på allt du undrar. Över 50 000 studenter pluggar redan här – byggt för att du ska lära dig snabbare och stressa mindre.